Cold-stored arterial allografts for in situ reconstruction of infected prosthetic grafts. Review of immunosuppressive protocols used in clinical practice
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064165%3A_____%2F16%3A10327091" target="_blank" >RIV/00064165:_____/16:10327091 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11110/16:10327091
Result on the web
<a href="http://dx.doi.org/10.1007/s10353-016-0401-9" target="_blank" >http://dx.doi.org/10.1007/s10353-016-0401-9</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s10353-016-0401-9" target="_blank" >10.1007/s10353-016-0401-9</a>
Alternative languages
Result language
angličtina
Original language name
Cold-stored arterial allografts for in situ reconstruction of infected prosthetic grafts. Review of immunosuppressive protocols used in clinical practice
Original language description
Introduction: Strong antigenicity of arterial allografts triggering immune response similar to rejection processes evident in solid organ transplant recipients was observed in animal experiments. A higher incidence of graft-related death, graft ruptures or thrombosis and graft aneurysm formation was observed in non-immunosuppressed patients after arterial implantation. Methodology: The use of immunosuppression is not generally accepted by vascular surgeons. In the cases in which immunosuppressive therapy is administered, the drug most frequently used is cyclosporine A (CyA). This therapy has shown good mid-term results with no signs of recurrent infection. New immunosuppressive protocols with tacrolimus or sirolimus were published recently. These drugs are routinely used in solid organ transplant patients and show some advantages, compared to cyclosporine A, with respect to hypertension, dyslipidaemia, and renal function. Results: The authors present available clinical immunosuppressive protocols in this indication and the results. Moreover, our group has published good experimental and clinical results with immunosuppressive protocol featuring the delayed use of tacrolimus after transplantation of cold-stored arterial allograft. Conclusion: All this long-term experience with immunosuppression suggests the hypothesis that this therapy has a place in the armamentarium of the vascular surgeon performing arterial allograft implantations.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FJ - Surgery including transplantology
OECD FORD branch
—
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
European Surgery-Acta Chirurgica Austriaca
ISSN
1682-8631
e-ISSN
—
Volume of the periodical
48
Issue of the periodical within the volume
Supplement 2
Country of publishing house
AT - AUSTRIA
Number of pages
3
Pages from-to
166-168
UT code for WoS article
000376594600014
EID of the result in the Scopus database
2-s2.0-84965026285